Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study

Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study

J Am Acad Dermatol. 2024 Jun 15:S0190-9622(24)00918-6. doi: 10.1016/j.jaad.2024.05.085. Online ahead of print.

NO ABSTRACT

PMID:38885841 | DOI:10.1016/j.jaad.2024.05.085